How demand-driven development will help new products be more successful.
Michael Murphy, MD, PhD
Advertisement
Chief Medical and Scientific Officer, Worldwide Clinical Trials
Articles by Michael Murphy, MD, PhD
Advertisement
Latest Updated Articles
Your Phase III Clinical Protocol Is Your Initial Product LaunchJanuary 30th 2026
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5